newsfilter
← Latest News
GlobeNewswire·

FDA Approves Telix’s Brain Cancer Imaging Drug Pixclara

Pixclara® is the first FDA-approved FET-PET imaging drug for glioma (brain cancer).Approval addresses a significant unmet need, helping physicians to differentiate recurrent or progressive glioma from treatment-related